StockTipsArenaBeta

BUY Shriram Finance Limited — Morgan Stanley

BUYShriram Finance Limited
Shriram Finance share price target & all analyst calls

byMorgan StanleyHorizon: NA (inferred 1 year)21 Aug 2026via ET Now (Live)

Entry₹1,129Inferred
Target₹1,340
Total upside +18.69%
Stop lossNot given
CMP₹8652d ago
Active-23.38%+54.91%upside left 10 mo left
Follow Morgan Stanley for new calls(97% target hit, 33 closed calls)Get alertsWatch SHRIRAMFIN for new buy/sell callsGet alertsSee 22 other Long-term calls on SHRIRAMFIN

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

As of 26 Oct, 12:01 am IST
28 supporting16 neutral6 opposing
Supports the BUY call (28)

Shriram Finance Q2 profit jumps 59% YoY to Rs 3,677 crore on strong interest income, lower funding costs

NewsEt-Markets·23 Oct · 2d ago

(opens in new tab)

Shriram Finance Q2 Results: Profit Jumps 59% To Rs 3,677 Crore, Dividend Declared | Check Record Date

NewsNdtv-Profit·23 Oct · 2d ago

(opens in new tab)

Long-term trend bullish — 200-day average rising over the past quarter

Technicals · trend·23 Oct · 2d ago

Multibagger stock: Up 30% in 1 year, Shriram Finance among top Nifty gainers - Should you buy stock ahead of Q2 results?

NewsLivemint·22 Oct · 3d ago

(opens in new tab)

14 other SEBI-registered advisors have active long-term BUY calls on this stock, with 1 issued in the last 14 days

Advisor consensus · same horizon·15 Oct · 1w ago

Neutral / worth noting (16)

Why Shriram Finance Wants To Double Down On Gold Loans Despite Repayment Red Flags

NewsNdtv-Profit·24 Oct · yesterday

(opens in new tab)

Approved and taken on record the unaudited standalone and consolidated financial results of the Company for the second quarter and half-year ended September 30, 2026, prepared pursuant ....

BSE · Board Meeting·23 Oct · 2d ago

(opens in new tab)

Approved and taken on record the unaudited standalone and consolidated financial results of the Company for the second quarter and half-year ended September 30, 2026, prepared pursuant to Regulation 33 and 52 of the Listing Regulations.

NSE · Outcome of Board Meeting·23 Oct · 2d ago

(opens in new tab)
Weighs against the BUY call (6)

Early gains fade by afternoon; Insurance, Pharma stocks pull indices lower

NewsHbl·14 Oct · 2w ago

(opens in new tab)

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Shriram Finance

All analyst calls on Shriram Finance

More from Morgan Stanley

Every call and its outcome